282 related articles for article (PubMed ID: 18375132)
1. Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins.
Jullian C; Morales-Montecinos J; Zapata-Torres G; Aguilera B; Rodriguez J; Arán V; Olea-Azar C
Bioorg Med Chem; 2008 May; 16(9):5078-84. PubMed ID: 18375132
[TBL] [Abstract][Full Text] [Related]
2. Molecular encapsulation of 5-nitroindazole derivatives in 2,6-dimethyl-beta-cyclodextrin: electrochemical and spectroscopic studies.
Pérez-Cruz F; Jullian C; Rodriguez J; Arán VJ; Olea-Azar C
Bioorg Med Chem; 2009 Jul; 17(13):4604-11. PubMed ID: 19464903
[TBL] [Abstract][Full Text] [Related]
3. Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: synthesis, electrochemical, electron spin resonance and molecular modeling studies.
Pérez-Cruz F; Aguilera-Venegas B; Lapier M; Sobarzo-Sánchez E; Uriarte Villares E; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 102():226-34. PubMed ID: 23220661
[TBL] [Abstract][Full Text] [Related]
4. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling.
Jullian C; Miranda S; Zapata-Torres G; Mendizábal F; Olea-Azar C
Bioorg Med Chem; 2007 May; 15(9):3217-24. PubMed ID: 17350847
[TBL] [Abstract][Full Text] [Related]
5. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
6. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
Bertholet P; Gueders M; Dive G; Albert A; Barillaro V; Perly B; Cataldo D; Piel G; Delattre L; Evrard B
J Pharm Pharm Sci; 2005 Jul; 8(2):163-74. PubMed ID: 16124927
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
[TBL] [Abstract][Full Text] [Related]
8. Melarsoprol-cyclodextrins inclusion complexes.
Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
[TBL] [Abstract][Full Text] [Related]
9. Characterization, phase solubility and molecular modeling of alpha-cyclodextrin/pyrimethamine inclusion complex.
de Araujo MV; Macedo OF; Nascimento Cda C; Conegero LS; Barreto LS; Almeida LE; da Costa NB; Gimenez IF
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Feb; 72(1):165-70. PubMed ID: 19019728
[TBL] [Abstract][Full Text] [Related]
10. NMR characterization of the host-guest inclusion complex between beta-cyclodextrin and doxepin.
Cruz JR; Becker BA; Morris KF; Larive CK
Magn Reson Chem; 2008 Sep; 46(9):838-45. PubMed ID: 18615634
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized beta-cyclodextrin.
Jullian C; Cifuentes C; Alfaro M; Miranda S; Barriga G; Olea-Azar C
Bioorg Med Chem; 2010 Jul; 18(14):5025-31. PubMed ID: 20576438
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexes of 2-chloroethylnitrososulfamides (CENS) with beta-cyclodextrin.
Kadri M; Dhaoui N; Abdaoui M; Winum JY; Montero JL
Eur J Med Chem; 2004 Jan; 39(1):79-84. PubMed ID: 14987836
[TBL] [Abstract][Full Text] [Related]
13. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
14. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
16. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.
Ribeiro L; Carvalho RA; Ferreira DC; Veiga FJ
Eur J Pharm Sci; 2005 Jan; 24(1):1-13. PubMed ID: 15626573
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR spectroscopic study of complexation of citalopram with beta-cyclodextrin in aqueous solution.
Mashhood Ali S; Maheshwari A; Inder Fozdar B
Magn Reson Chem; 2007 Mar; 45(3):253-6. PubMed ID: 17290386
[TBL] [Abstract][Full Text] [Related]
18. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
19. Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: molecular modeling studies.
Barillaro V; Dive G; Bertholet P; Evrard B; Delattre L; Eric Z; Piel G
Int J Pharm; 2007 Sep; 342(1-2):152-60. PubMed ID: 17573213
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamics of propylparaben/beta-cyclodextrin inclusion complexes.
Zughul MB; al-Omari M; Badwan AA
Pharm Dev Technol; 1998 Feb; 3(1):43-53. PubMed ID: 9532599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
